Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Completed · Phase 1/Phase 2

Conditions studied: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm

In brief

RATIONALE: Omega-3 fatty acids are used by the body for energy and tissue development and may be an effective treatment for patients with advanced cancer who are unable to maintain their body weight. PURPOSE: Phase I/II trial to study the effectiveness of omega-3 fatty acids in treating patients with advanced cancer who have significant weight loss.

Key facts

Study ID

NCT00003077

Run by

Alliance for Clinical Trials in Oncology

People needed

63

Starts

1995-10-01

Expected to finish

2004-11-01

Last updated by the study team

2016-07-13

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CCOP - Christiana Care Health Services — Wilmington, Delaware, United States
• Holden Comprehensive Cancer Center at The University of Iowa — Iowa City, Iowa, United States
• North Shore University Hospital — Manhasset, New York, United States
• New York Presbyterian Hospital - Cornell Campus — New York, New York, United States
• CCOP - Southeast Cancer Control Consortium — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.